Hypersomnia in Major Depressive Disorder

计划入组 350 人 · 首次发布于 2019 年 7 月 5 日

NMDA Modulation in Major Depressive Disorder

计划入组 90 人 · 首次发布于 2020 年 11 月 20 日

Neurocognitive Enhancement in Major Depressive Disorder

计划入组 33 人 · 首次发布于 2009 年 10 月 20 日

positive allosteric NMDA receptor modulator (major depressive disorder)

SRXXX (Depressive Disorder, Major)

Tranylcypromine(Parnate)

C₉H₁₁N · Rx

Brainsway

Israel

Alzamend Neuro

United States

MAJOR MEDICAL SUPPLY

United States

FDA Approves Axsome's Auvelity for Major Depressive Disorder Treatment

MindMed Advances LSD Development Program for Major Depressive Disorder Treatment

FDA Approves Exxua (Gepirone ER), a Novel Selective 5-HT1A Receptor Agonist for Major Depressive Disorder